LILLE 1 University - Science and Technology

University / College


Location: Lille, France (FR) FR

ISNI: 0000000122426780

ROR: https://ror.org/02kzqn938

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis (2019) Vermersch P, Martinelli V, Pfleger C, Rieckmann P, Alonso-Magdalena L, Galazka A, Dangond F, Phillips L Journal article Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement (2019) Yoon SH, Bleiziffer S, Latib A, Eschenbach L, Ancona M, Vincent F, Kim WK, et al. Journal article Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology (2019) Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, Hoa S, et al. Journal article Status of Six-Port Technology for Wireless Sensing Applications (2018) Haddadi K, Loyez C, Lallemand S, Kölpin A Conference contribution, Conference Contribution Broadband bright twin beams and their upconversion (2018) Chekhova MV, Germanskiy S, Horoshko DB, Kitaeva GK, Kolobov MI, Leuchs G, Phillips CR, Prudkovskii PA Journal article How to quantify the value of domino combinations? Divination and shifting rationalities in late imperial China (2018) Bréard A Book chapter / Article in edited volumes Oligomannose-Rich Membranes of Dying Intestinal Epithelial Cells Promote Host Colonization by Adherent-Invasive E. coli (2018) Dumych T, Yamakawa N, Sivignon A, Garenaux E, Robakiewicz S, Coddeville B, Bongiovanni A, et al. Journal article Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study (2018) Jaeger VK, Siegert E, Hachulla E, Airo P, Valentini G, Matucci-Cerinic M, Scorza R, et al. Conference contribution Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease (2018) Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al. Journal article Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study (2018) Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, et al. Journal article